Correlation Between Rigel Pharmaceuticals and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Immutep Ltd ADR, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Immutep.

Diversification Opportunities for Rigel Pharmaceuticals and Immutep

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rigel and Immutep is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Immutep go up and down completely randomly.

Pair Corralation between Rigel Pharmaceuticals and Immutep

Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 2.38 times more return on investment than Immutep. However, Rigel Pharmaceuticals is 2.38 times more volatile than Immutep Ltd ADR. It trades about 0.35 of its potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.14 per unit of risk. If you would invest  1,420  in Rigel Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  1,341  from holding Rigel Pharmaceuticals or generate 94.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Rigel Pharmaceuticals  vs.  Immutep Ltd ADR

 Performance 
       Timeline  
Rigel Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Immutep Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Rigel Pharmaceuticals and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rigel Pharmaceuticals and Immutep

The main advantage of trading using opposite Rigel Pharmaceuticals and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind Rigel Pharmaceuticals and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements